• +1-646-491-9876
    • +91-20-67278686

    Search

    Pancreatitis - Pipeline Review, H1 2017

    Pancreatitis - Pipeline Review, H1 2017

    • Report Code ID: RW0001767491
    • Category Pharmaceuticals
    • No. of Pages 70
    • Publication Month Apr-17
    • Publisher Name Global Markets Direct
    Pancreatitis - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Pipeline Review, H1 2017, provides an overview of the Pancreatitis (Gastrointestinal) pipeline landscape.

    Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Pancreatitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Pancreatitis (Gastrointestinal) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Pancreatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 1, 13, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 1 molecules, respectively.

    Pancreatitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatitis (Gastrointestinal) .
    - The pipeline guide reviews pipeline therapeutics for Pancreatitis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Pancreatitis (Gastrointestinal) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Pancreatitis (Gastrointestinal) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatitis (Gastrointestinal)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Pancreatitis (Gastrointestinal) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Pancreatitis (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Pancreatitis - Overview
    Pancreatitis - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Pancreatitis - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Pancreatitis - Companies Involved in Therapeutics Development
    Angion Biomedica Corp
    Atox Bio Ltd
    Bharat Serums And Vaccines Ltd
    CalciMedica Inc
    Cypralis Ltd
    Dynavax Technologies Corp
    Generon (Shanghai) Corp Ltd
    GlaxoSmithKline Plc
    LipimetiX Development Inc
    Novartis AG
    Pharming Group NV
    Sun BioPharma Inc
    Pancreatitis - Drug Profiles
    AB-103 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    AEM-2802 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    AEM-2814 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ANG-3070 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    C1 esterase inhibitor (recombinant) - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CM-128 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CM-4620 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    DV-1179 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    F-652 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    GSK-180 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    GSK-2795039 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    GSK-6288B - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ND-07 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    P-2pal18S - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Recombinant Protein to Inhibit CXCL for Pancreatitis, Cardiovascular and Immunology - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    SBP-101 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    SBP-102 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecule to Block TRPV4 and TRPA1 for Pancreatitis and Trigeminal Neuralgia - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecule to Inhibit Cyclophilin D for Acute Pancreatitis - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit Soluble Epoxide Hydrolase for Acute Pancreatitis - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit Trypsin for Pancreatitis - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    SP-20201 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ulinastatin - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Withaferin A - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Pancreatitis - Dormant Projects
    Pancreatitis - Discontinued Products
    Pancreatitis - Product Development Milestones
    Featured News & Press Releases
    Feb 01, 2017: The NIH Awards Sun BioPharma Grant to Study SBP-101 for the Treatment of Pancreatitis
    Jan 05, 2017: CalciMedica Initiates Phase 1 Clinical Studies for CRAC Channel Inhibitor
    Oct 24, 2016: Sun BioPharma to Present at the Innovation Biotech Showcase on October 26th
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Pancreatitis, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Pancreatitis - Pipeline by Angion Biomedica Corp, H1 2017
    Pancreatitis - Pipeline by Atox Bio Ltd, H1 2017
    Pancreatitis - Pipeline by Bharat Serums And Vaccines Ltd, H1 2017
    Pancreatitis - Pipeline by CalciMedica Inc, H1 2017
    Pancreatitis - Pipeline by Cypralis Ltd, H1 2017
    Pancreatitis - Pipeline by Dynavax Technologies Corp, H1 2017
    Pancreatitis - Pipeline by Generon (Shanghai) Corp Ltd, H1 2017
    Pancreatitis - Pipeline by GlaxoSmithKline Plc, H1 2017
    Pancreatitis - Pipeline by LipimetiX Development Inc, H1 2017
    Pancreatitis - Pipeline by Novartis AG, H1 2017
    Pancreatitis - Pipeline by Pharming Group NV, H1 2017
    Pancreatitis - Pipeline by Sun BioPharma Inc, H1 2017
    Pancreatitis - Dormant Projects, H1 2017
    Pancreatitis - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Pancreatitis, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    Angion Biomedica Corp
    Atox Bio Ltd
    Bharat Serums And Vaccines Ltd
    CalciMedica Inc
    Cypralis Ltd
    Dynavax Technologies Corp
    Generon (Shanghai) Corp Ltd
    GlaxoSmithKline Plc
    LipimetiX Development Inc
    Novartis AG
    Pharming Group NV
    Sun BioPharma Inc

    Request for Sample

    Report Url http://www.reportsweb.com//pancreatitis-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//pancreatitis-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//pancreatitis-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments